Check out your Company Bowl for anonymous work chats.
The wait is almost over: #ECR2026 is just around the corner, the countdown to Europe’s largest congress in radiology and imaging has officially begun! 📍 You’ll find our team at the Austria Center Vienna, booth AI-34, within the X1 – AI Expo zone. Ready to discover the full potential of radiomics? Let’s connect — book a meeting here https://bit.ly/3ZsHpkl #ECR26 #ECR #Radiology #MedicalImaging
Presentamos #APOLO, el nuevo Clúster de la Industria de Defensa de la Comunitat Valenciana, una iniciativa que reúne a empresas, centros tecnológicos y universidades para impulsar la innovación dual, la competitividad industrial y la autonomía tecnológica. Desde Quibim nos enorgullece formar parte de este proyecto estratégico que busca articular capacidades, generar nuevas oportunidades de colaboración y reforzar la posición de la Comunitat Valenciana como polo de referencia en tecnologías aplicadas a la defensa. La Junta Directiva del clúster está presidida por S2GRUPO, representada por su CEO, José Miguel Rosell Tejada, y cuenta con la participación de Fernando Gastaldo Lázaro, Director General de FACTOR Ingeniería y Decoletaje; Fernando Gómez, CEO B-libe; Javier Quilis, CEO de INELCOM, Ingeniería Electrónica Comercial; y Ángel Alberich-Bayarri, CEO de Quibim, reflejando la diversidad sectorial del proyecto en su fase inicial. La visión de APOLO es convertir a la Comunitat Valenciana en un referente nacional e internacional en investigación, innovación, diseño, fabricación y tecnología aplicada a la defensa, apoyándose en su base empresarial, su ecosistema innovador y su capacidad logística y de talento. #ClústerAPOLO #IndustriaDeDefensa #ComunitatValenciana
On #WorldCancerDay, we showcase Communications Medicine's insights into addressing a fundamental question in healthcare: how is innovation transforming the global fight against cancer? The article “𝘈𝘳𝘵𝘪𝘧𝘪𝘤𝘪𝘢𝘭 𝘐𝘯𝘵𝘦𝘭𝘭𝘪𝘨𝘦𝘯𝘤𝘦 𝘧𝘰𝘳 𝘉𝘳𝘦𝘢𝘴𝘵 𝘊𝘢𝘯𝘤𝘦𝘳 𝘛𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵” highlights four key takeaways that may be applicable to other types of cancer, based on the latest evidence. • AI may help improve diagnostic accuracy in imaging and pathology. • Personalized treatment plans improve patient outcomes. • Smarter clinical decisions help reduce unnecessary interventions. • Challenges remain: adoption, regulation, and equitable access. Regardless of our role in healthcare, World Cancer Day reminds us that we must invest, collaborate, and innovate to achieve a future where cancer is not only treatable, but also more preventable. https://lnkd.in/enEKT5Cc Springer Nature #AIinHealthcare #PrecisionMedicine #CancerResearch #BreastCancer
Thank you to everyone who joined us at the BAUS North West Urology Meeting in Manchester. It was a pleasure to connect with the urology community and share how AI is advancing #ProstateCancer care pathways. If you didn't get a chance to meet us, we'd love to continue the conversation. Feel free to contact our team or request a demo: https://bit.ly/4bvwRbx Francesca Evans Maria Proud , MHA Sid Singh Adesina Adesuyi George Eliot Hospital NHS Trust #MedicalImaging #AIinHealthcare #Innovation #Urology
We look forward to connecting with the community at the 25th PMWC - Precision Medicine World Conference 2026, taking place March 4–6 in Santa Clara, California, co-hosted by Stanford University, University of California, San Francisco, and Yale University. On March 4, our CEO will lead the session “𝘈𝘐-𝘌𝘯𝘩𝘢𝘯𝘤𝘦𝘥 𝘐𝘮𝘢𝘨𝘪𝘯𝘨: 𝘙𝘢𝘥𝘪𝘰𝘮𝘪𝘤𝘴, 𝘙𝘢𝘥𝘪𝘰𝘨𝘦𝘯𝘰𝘮𝘪𝘤𝘴 & 𝘚𝘪𝘮𝘶𝘭𝘢𝘵𝘪𝘰𝘯”, exploring how Quibim’s technology is transforming decision-making in drug development and precision health. Don’t miss it! Tal Behar #PMWC26 #PrecisionMedicine #Biotech
À Punt Radiotelevisió Valenciana se hizo eco ayer, Día Internacional del Cáncer, de cómo la innovación con sello valenciano se está exportando al resto del mundo para mejorar la vida de los pacientes, impulsando la prevención y el diagnóstico temprano. Para Quibim es un orgullo formar parte de un ecosistema científico vibrante, con ambición internacional, pero con un fuerte compromiso local. 🗞️ Artículo completo: https://web.apunt.es/cfsYl #Cancer #InnovaciónEnSalud #IAEnMedicina
Quibim was present as an industry partner at the 8th Annual Practical Urology Conference in Los Angeles, organized by the USC Institute Of Urology, one of our newest partners. If you haven’t yet seen how QP-Prostate streamlines fusion biopsy and focal therapy with AI—bringing radiology and urology into closer alignment to improve #ProstateCancer outcomes—you can still book a demo: https://bit.ly/4bvwRbx #AIinHealthcare #Urology #Radiology #MedicalImaging #PrecisionMedicine
AI has the potential to greatly improve how we assess treatment response in oncology, but that potential can only be realized through collaborative efforts to rigorously validate new methods and proposed standards. We are proud to participate in the ai.RECIST working group led by Friends of Cancer Research, which promotes AI-based tumor assessments that are validated, interpretable, and ready for regulatory decision-making. As a contributing member, our tool that automatically detects, measures, and tracks lesions across timepoints will be evaluated in the planned study. 📄 This white paper outlines: ✔️ Limitations of current imaging-based endpoints and opportunities to advance beyond #RECIST ✔️ Emerging AI-driven approaches, including enhanced RECIST, radiomics, volumetric analysis, and growth kinetics ✔️ Key elements of a framework to validate novel AI-based imaging endpoints, including outstanding questions around endpoint definition and considerations for meta-analysis https://bit.ly/3MaUTy8 #AIinHealthcare #MedicalImaging #ClinicalTrials #CancerResearch #LifeSciences
This scoping review published in Cureus Journal of Medical Science analyzes the role of artificial intelligence in reducing error rates in radiology, highlighting how AI can help clinicians. As the volume and complexity of images increase, evidence-based analyses such as this one are essential to understanding where AI already adds value and how it can be responsibly expanded in real-world practice. Read the full article: https://lnkd.in/ergY6qZg #MedicalImaging #AIinHealthcare #Innovation
We start 2026 strong. Reinforcing our commitment to the Life Sciences sector, we’re proud to welcome Dr Jeanne Bolger, MB BCh BAO, as Independent Director and Advisor at Quibim. With decades of healthcare experience, Jeanne will support strategic collaborations with pharmaceutical leaders and help accelerate innovation across oncology, immunology, and neurology. Her appointment strengthens a Board that brings together leaders from global healthcare and investment, and marks an important milestone in our strategy to expand Quibim’s life sciences footprint worldwide. https://bit.ly/4rBpFzt #LifeSciences #Innovation #Oncology #Immunology #Neurology
